Azenta, Inc. (NASDAQ:AZTA – Get Free Report) has been assigned a consensus rating of “Hold” from the six research firms that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $69.60.
A number of brokerages have recently weighed in on AZTA. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 price target on shares of Azenta in a research note on Monday, April 8th. Evercore ISI reduced their price target on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research note on Thursday, April 4th. Stephens reaffirmed an “equal weight” rating and issued a $70.00 price target on shares of Azenta in a research note on Thursday, February 8th. Jefferies Financial Group began coverage on shares of Azenta in a research note on Thursday, April 4th. They issued a “hold” rating and a $64.00 price target for the company. Finally, B. Riley increased their target price on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research note on Thursday, February 1st.
View Our Latest Analysis on AZTA
Azenta Trading Down 2.6 %
Azenta (NASDAQ:AZTA – Get Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share for the quarter. The company had revenue of $154.32 million during the quarter, compared to analyst estimates of $151.86 million. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. As a group, equities research analysts expect that Azenta will post 0.27 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Azenta
Large investors have recently made changes to their positions in the company. TFC Financial Management Inc. acquired a new stake in shares of Azenta during the third quarter valued at approximately $25,000. Principal Securities Inc. acquired a new stake in shares of Azenta during the fourth quarter valued at approximately $36,000. Headlands Technologies LLC acquired a new stake in shares of Azenta during the third quarter valued at approximately $33,000. Northwest Financial Advisors acquired a new stake in shares of Azenta during the fourth quarter valued at approximately $46,000. Finally, Point72 Europe London LLP acquired a new stake in shares of Azenta during the fourth quarter valued at approximately $48,000. Institutional investors and hedge funds own 99.08% of the company’s stock.
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- The 3 Best Fintech Stocks to Buy Now
- Silicon Motion Proves That AI in Motion Stays in Motion
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Undervalued UnitedHealth Group Won’t Be For Long
- 3 Warren Buffett Stocks to Buy Now
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.